Mitochondria are known to be central to the cell's response to ischemia, because of their role in energy generation, in free radical generation, and in the regulation of apoptosis. Heat shock protein 75 (Hsp75/Grp75/mortalin/TRAP1) is a member of the HSP70 chaperone family, which is targeted to mitochondria. Overexpression of Hsp75 was achieved in rat brain by DNA transfection, and expression was observed in both astrocytes and neurons. Rats were subjected to 100 mins middle cerebral artery occlusion followed by assessment of infarct volume, neurological score, mitochondrial function, and levels of oxidative stress at 24 h reperfusion. Overexpression of Hsp75 reduced infarct area from 44.6% ± 21.1% to 25.7% ± 12.1% and improved neurological outcome significantly. This was associated with improved mitochondrial function as shown by protection of complex IV activity, marked reduction of free radical generation detected by hydroethidine fluorescence, reduction of lipid peroxidation detected by 4-hydroxy-2-nonenol immunoreactivity, and increased preservation of ATP levels. This suggests that targeting mitochondria for protection may be a useful strategy to reduce ischemic brain injury.
Introduction
Ischemic brain injury is caused by the interruption of cerebral blood flow leading to both acute and delayed degeneration of brain cells. Mitochondrial function is involved in the maintenance of cellular homeostasis and in life/death decisions (Bambrick et al, 2004; Fiskum, 2000; Zipfel et al, 2000) . Multiple mechanisms contribute to mitochondrial dysfunction during and after ischemia. Mitochondrial electron transport constitutively results in production of reactive oxygen species (ROS), including superoxide radicals and hydrogen peroxide, under normal physiological conditions (Boveris and Chance, 1973) . Ischemia and subsequent reperfusion cause ROS overproduction by mitochondria, leading to an increase in oxidative stress (Saito et al, 2005; Siesjo et al, 1989) .
Many cell functions including neurotransmitter turnover and ion homeostasis require ATP. Mitochondrial ATP production through oxidative phosphorylation is the major energy source for brain cells (Edmond et al, 1987) . Ischemia-induced mitochondrial damage leads to severe ATP depletion, thus compromising ionic balance, neuronal signaling, and other vital processes (Dienel and Hertz, 2005; Hata et al, 2000) . Severe ischemia induces loss of mitochondrial membrane potential, which initiates both apoptotic and necrotic mechanisms of cell death (Gottlieb et al, 2003; Honda et al, 2005) . Loss of mitochondrial potential has been shown to be a key event in the demise of neurons and astrocytes under ischemic conditions (Juurlink and Hertz, 1993) . Therefore, protection of mitochondrial homeostasis and function during ischemic injury represents a promising therapeutic target for the reduction of ischemic brain injury.
Heat shock protein 75 (Hsp75/mtHsp70/Grp75/ mortalin/TRAP-1) is the mitochondrial localized member of the heat shock protein 70 (HSP70) family and is an essential mitochondrial chaperone. It bindsprotein 75 also associates with other mitochondrial proteins including Hsp60, voltage-dependent anionselective channel, and nicotinamide adenine dinucleotide (NADH) dehydrogenase, thus making it an important part of the mitochondrial machinery (Bhattacharyya et al, 1995; Schwarzer et al, 2002) . Heat shock protein 75 is not heat-inducible, but like other HSP70 members, has been shown to be upregulated by various cellular insults including glucose deprivation, oxidative stress, thyroid hormone treatment, and ultraviolet A radiation (Carette et al, 2002; Hadari et al, 1997; Lee, 2001; Mitsumoto et al, 2002) . Heat shock protein 75 induction was also found after focal cerebral ischemia by Massa et al (1995) . Increased Hsp75 levels have been shown to be associated with protection against apoptotic death in smooth muscle (Taurin et al, 2002) .
So far, several in vitro studies have demonstrated the protective potential of Hsp75 overexpression against ischemia-like injury. In cardiac myocytes exposed to hypoxia/reoxygenation Hsp75 overexpression protected from mitochondrial injury and development of apoptosis (Williamson et al, 2008) . Protective effects of Hsp75 overexpression in brain cells have also been reported Voloboueva et al, 2007) . Increased levels of Hsp75 suppressed rapid ROS accumulation in a neuronal cell line , and decreased ROS production, preserved mitochondrial function, and increased cell viability in primary astrocytes exposed to ischemia-like injury in vitro (Voloboueva et al, 2007) . Despite the evidence of protection by Hsp75 in vitro, studies of the effect of Hsp75 overexpression on brain ischemia/reperfusion injury or mitochondrial function in vivo are lacking. The purpose of this study was to investigate the effects of Hsp75 overexpression in the brains of rats subjected to transient middle cerebral artery occlusion on the size of the infarct area, levels of oxidative stress, and mitochondrial function.
Materials and methods

Overexpression of Hsp75 in Brain
The Hsp75 coding sequences from pBluescript-Hsp75 (a kind gift from R Morimoto, Northwestern University) were PCR amplified using the following primers: GGCCC GTCGGGCCTGCCTCGTACTCCT and GGCCCGATAGGCCG GAAGTCTCTTCACTCCTAAG, to produce a product flanked by two sites for the restriction endonuclease SfiI. This was subcloned into pCR2.1 (Invitrogen, Carlsbad, CA, USA), cut out with SfiI and subcloned into a modification of pL_UGIN carrying two SfiI sites in place of the enhanced green fluorescent protein (eGFP) sequences. This was used as an expression construct with Hsp75 expression driven by the human ubiquitin c promoter. Previous work demonstrated that this is a strong, ubiquitous promoter for expression in mice (Schorpp et al, 1996) . Controls were injected with the original pL_UGIN plasmid encoding eGFP, a kind gift from Dr Iain Fraser (California Institute of Technology, USA).
DNA/lipid complex was prepared and injected intracerebroventricularly as described previously (Sun et al, 2006) . Briefly, adult male Sprague-Dawley rats (280 to 310 g) were anesthetized by face mask with isoflurane in 70% N 2 O and 30% O 2 and placed in a stereotaxic frame with a rat head holder. DNA (10 mg) of the expression plasmid encoding Hsp75 or plasmid encoding eGFP, referred to as vector in the following text, was mixed with the cationic lipid DOTAP (1:3 mg/ml; Roche Applied Science, Indianapolis, IN, USA). After mixing for 5 secs, and incubating at 371C for 15 mins the mixture was infused into the right lateral cerebral ventricle at a speed of 2 ml/mins via a burr hole. After that the bone wound was closed with bone wax, anesthesia was discontinued, and rats were returned to their cages. Two days after the injection rats were either killed to assess Hsp75 expression, or subjected to focal ischemia on the contralateral side.
Focal Cerebral Ischemia
Transient ischemia was induced using the suture occlusion technique, as previously described (Sun et al, 2006) , with slight modifications. Male, 280 to 310 g Sprague-Dawley rats were anesthetized, and the left external carotid artery (ECA) was exposed and dissected. A 3-0 monofilament nylon suture (from Doccol Co., Redlands, CA, USA) was inserted from the ECA into the internal carotid artery to occlude the left middle cerebral artery (MCA) at its origin. After 100 mins, the suture was removed for reperfusion, the ECA was ligated, and the wound was closed. Shamoperated animals underwent identical procedures, except for the suture insertion. Rectal temperature were maintained at 371C±0.51C controlled by a Homeothermic blanket control unit (Harvard Apparatus, Holliston, MA, USA). Temperature, respiratory rate, oxygen saturation, and heart rate were monitored during the surgery, and after reanesthetizing the animals to remove the suture at 100 mins, with a small animal Oximeter (STARR Life Sciences Corp., Allison Park, PA, USA). At 24 h after surgery, rats were tested for neurological score before being killed.
Infarct Volume Measurements
The rats were anesthetized with isoflurane and brains were rapidly removed 24 h after middle cerebral artery occlusion (MCAO). Sections were incubated in 2% 2,3,5-triphenyltetrazolium chloride in saline for 20 mins at 371C. The infarct area was measured by a blinded observer on 6 sections per brain using digital imaging and image analysis software (ImageJ, version 1.37; Wayne Rasband, available through NIH) corrected for edema as previously described (Sun et al, 2006) .
Neurological Deficit Score
The neurological deficit score was assessed 24 h after MCAO as described previously (rating scale: 0 = no deficit, Hsp75 protects from focal ischemia L Xu et al 1 = failure to extend the right forepaw, 2 = circling to the right, 3 = falling to the right, 4 = unable to walk spontaneously) (Menzies et al, 1992) .
Immunohistochemistry, Lipid Peroxidation Assessment of HNE
Ischemic or sham-operated rats were anesthetized and perfused with 0.9% saline, followed by 4% paraformaldehyde in phosphate-buffered saline (PBS) (pH 7.4). The brains were kept in 4% paraformaldehyde in PBS (pH 7.4) for 48 h then cut in 50 mm sections. Sections were immunostained using anti-glial fibrillary acidic protein (anti-GFAP, 1:3 dilution; Immunostar, Hudson, WI, USA) to label astrocytes or rabbit anti-microtubule-associated protein 2 (anti-MAP2) (1:2000 dilution; Chemicon, Temecula, CA, USA) to identify neurons, and anti-Hsp75 antibody (1:500; Abcam, Cambridge, MA, USA). Antibody to 4-hydroxy-2-nonenal (HNE) (Oxis, 1:200) was used to determine levels of lipid oxidation. After washing, the slices were incubated with corresponding Alexa Fluor 488-or 594-conjugated secondary antibodies (Invitrogen; 1:200), washed and mounted on glass slides using Vectashield mounting medium with 4 0 ,6-diamidino-2-phenylindole (DAPI; Vector Laboratories, Burlingame, CA, USA). The border between normal appearing cells and infarcted tissue is readily identified after 24 h (Dingman et al, 2006) by the morphological appearance of nuclei. The core was identified as the region in which the majority of 4 0 ,6-diamidino-2-phenylindole stained nuclei were shrunken, whereas the penumbra was defined as the region of generally morphologically normal cells, approximately 500 mm wide, surrounding the core. To quantify levels of lipid oxidation, HNE reactivity was visualized and the average fluorescence intensity was measured in three brain sections (À1.5 to 2.5 mm relative to Bregma). At least six areas of 0.05 mm 2 , in both cortical and striatal areas, were quantified in the penumbra and in the corresponding nonischemic contralateral areas of the brain for each of three animals per group.
Measurement of ROS
ROS in brain parenchyma oxidizes HEt to ethidium, the fluorescence of which can be visualized in brain sections. HEt (Molecular Probes, Eugene, OR, USA) 0.5 mg in 200 ml saline was administered by tail vein 23 hours after MCAO; animals were killed one hour later. The brains were fixed in 4% paraformaldehyde in PBS for 48 h, 50 mm sections were prepared, and HEt fluorescence intensity determined and quantified as described above for HNE measurements.
Western Blotting
For western blotting rats were killed 48 h after Hsp75 or vector DNA injection. The brains were removed and immediately homogenized in cold lysis buffer (10 mmol/L 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (pH 7.9), 1.5 mmol/L MgCl 2 , 10 mmol/L KCl, 1 mmol/L dithiothreitol) plus protease inhibitor cocktail (Roche Diagnostics, Mannheim, Germany). Protein concentrations were determined by the bicinchoninic acid method (Pierce, Rockford, IL, USA). Equal amounts (50 mg) of protein were loaded and separated on a 4% to 15% polyacrylamide gel (Bio-Rad, Hercules, CA, USA), and electrotransferred to Immobilon polyvinylidene fluoride membrane (Millipore Corp., Bedford, MA, USA). Membranes were blocked with 5% nonfat dry milk in PBS with 0.1% Tween 20 for 1 h, incubated overnight with 1:1000 primary anti-Hsp75 antibody (Stressgen, Ann Arbor, MI, USA), washed three times with 0.1% Tween in PBS, and incubated with 1:2,000 antimouse antibody, 5% milk, and 0.1% Tween in PBS, for 90 mins. Immunoreactive bands were visualized with the enhanced chemiluminescence detection system (Amersham, Piscataway, NJ, USA) according to the manufacturer's protocol. Equal protein loading was assessed by Ponceau S solution staining.
Measurements of Mitochondrial Complex Activities
Preparation of mitochondria: brain tissue was finely minced in cold isolation medium containing 0.32 mol/L sucrose, 1 mmol/L potassium-ethylenediaminetetraacetic acid and 10 mmol/L Tris-HCl (pH 7.4) and adjusted to a final concentration of 1 g of tissue/10 ml of medium. The minced tissue was homogenized with a Polytron tissue processor. The homogenate was centrifuged at 1,000g (41C) for 10 mins. The supernatant was transferred to a clean tube and the mitochondrial pellet was obtained by centrifugation at 12,000g (41C) for 15 mins. The assays for complex activities were modified from the procedure described by Pandey et al (2008) . NADH-ubiquinone oxidoreductase (complex I): the reaction was followed spectrophotometrically using a microplate reader at 340 nm for 3 mins at 371C in a solution containing 40 to 50 mg of the submitochondrial particles, 35 mmol/L potassium phosphate buffer, pH 7.4, 2.65 mmol/L NaN 3 , 1 mmol/ L ethylenediaminetetraacetic acid, 5 mmol/L MgCl 2 , 200 mmol/L NADH as donor, and 100 mmol/L coenzyme Q 0 as acceptor. Succinate dehydrogenase (complex II): activity was monitored spectrophotometrically at 600 nm for 1 min in a reaction mixture containing 50 mmol/L potassium phosphate buffer, pH 7.5, 40 mmol/L sodium succinate, 750 mmol/L NaN 3 , 290 mmol/L phenazonium methosulphate, and 50 mmol/L DCIP. Ubiquinol-cytochrome c oxidoreductase (complex III): the reduction of cytochrome c was monitored as increase in absorbance at 550 nm for 3 mins in the presence of 5 mmol/L rotenone. The reaction mixture consisted of 50 mmol/L potassium phosphate buffer, pH 7.4, containing 1 mmol/L ethylenediaminetetraacetic acid potassium salt, 20 mmol/L NaN 3, 50 mmol/L cytochrome c, and 5 to 10 mg sub-mitochondrial protein, which was incubated at 301C for 1 mins, before starting the reaction by the addition of 100 mmol/L NADH. Cytochrome c oxidase (complex IV): the activity of complex-IV was measured using a cytochrome c oxidase assay kit (CYTOX-OX1; Sigma, St Louis, MO, USA), taking reduced cytochrome c as the donor. The oxidation of cytochrome c was monitored as the decrease in absorbance Hsp75 protects from focal ischemia L Xu et al at 550 nm using a microplate reader and the initial rate of cytochrome c reduction was used for the calculation of activity. Protein concentration was measured using the Bio-Rad protein assay kit and the mitochondrial complex activities were normalized by dividing them by protein concentration and expressing as a ratio to normal control.
ATP Measurements
At 24 h after MCAO rats (four per group) were anesthesized with isoflurane and decapitated. Brains were removed and immediately dissected on a cold À201C board. In each hemisphere, the region À1.5 to 2.5 mm Bregma, which our previous studies have indicated show the most pronounced injury, was collected and quick-frozen in liquid nitrogen. The brain specimens were next placed in 0.4 mol/L perchloric acid (10 mL/g), homogenized, and centrifuged at 500g for 5 mins. The supernatant was neutralized with 150 mL of 2 mol/L K 2 CO 3 added to 1 mL of supernatant, and recentrifuged. The resulting supernatants were stored at À801C until measurement. Cellular ATP concentrations were measured using the CellTiter-Glo luminescent ATP assay kit, based on the luciferase/luciferin reaction (Promega, Madison, WI, USA) according to the manufacturer's instructions. The luminescence measurements of the samples in opaque white 96-well plates were performed using a Veritas luminescence counter (Turner BioSystems, Sunnyvale, CA, USA). ATP standards (Sigma) were used for calibration.
Statistics
Data are presented as the mean ± s.d. The differences between groups were determined by T-test for unpaired data and differences between multiple groups for ATP levels and fluorescence were determined using analysis of variance followed by post hoc Tukey's multiple comparison test. Differences were considered significant at P < 0.05.
Results
Expression of Hsp75 in Neurons and Astrocytes in Brain
We investigated the anatomic spread and cell type expression of Hsp75 by immunohistochemistry 48 h after unilateral injection of plasmid DNA encoding Hsp75 into the lateral ventricle. As shown in Figure 1 , we observe widespread expression of Hsp75 protein throughout the brain, bilaterally and with broad rostral-caudal spread. As shown in Figure 2 by double label immunohistochemistry, Hsp75 overexpression was observed in the bodies and processes of both astrocytes (Figure 2A) , and neurons ( Figure  2B ). We also investigated levels of Hsp75 expression in brain by western blotting of brain protein with Hsp75 antibody. Figures 2C and 2D show that Hsp75-injected brains demonstrated significantly higher levels of Hsp75 expression compared with vectorinjected, and control uninjected brain (endogenous Hsp75 levels, were comparable to vector injected, data not shown).
Hsp75 Overexpression Decreases Infarct Volume and Improves Neuroscore
Rats were subjected to MCAO 48 h after Hsp75 or vector injection because both immunohistochemistry and western blotting confirmed Hsp75 overexpression at this time point. The physiological variables of (1) Superior cortex including primary motor cortex (penumbral area), (2) striatum (infarct area), (3) medial cortex plus lateral striatum (infarct and most protected area), and (4) inferolateral cortex (seldom included in infarct area) in both vector-and Hsp75-injected brain slices. Photomicrographs were taken at the same fluorescence exposure for vector-and Hsp75-injected brains. (B) Hsp75 fluorescence from representative coronal sections at different levels relative to bregma of an Hsp75 injected brain. Left column of cresyl violet stained sections indicates the approximate regions from which the images in the right column were taken.
Hsp75 protects from focal ischemia L Xu et al temperature, oxygen saturation, and heart rate are given in Table 1 . The temperature and heart rate were increased at the end of 100 mins MCAO compared with either before or at the beginning of MCAO (P < 0.05), but did not differ between groups at any time point. Figure 3 shows that Hsp75 overexpressing animals (N = 10) demonstrated a 43% reduction of infarct volume compared with vector only injected rats (N = 10), as evidenced by 2,3,5-triphenyltetrazolium chloride (TTC) staining. The neuroscores were 1.63 ± 0.53 and 2.23 ± 0.75, respectively, for Hsp75 (n = 12) and vector-injected (n = 11) groups. The difference was significant at P = 0.036.
Oxidative Stress is Reduced with Hsp75 Overexpression
Oxidative stress and damage were evaluated using HEt fluorescence and HNE immunocytochemistry. Figure 4A shows that Hsp75 overexpression resulted in decreased levels of HEt fluorescence in the penumbra of the ischemic brains. Vector-injected animals demonstrated a 1.9-fold rise in HEt fluorescence compared with HEt staining of contralateral brain areas, whereas there was only a 1.26-fold rise in HEt fluorescence in HSP75-injected animals ( Figure 4B ), significantly less. To investigate whether Hsp75 protects from focal ischemia L Xu et al decreased ROS levels were associated with decreased oxidative cell damage, we used HNE antibody to identify oxidized lipids. Figure 4C demonstrates that the penumbra of vector-injected animals demonstrated significantly higher levels of HNE staining compared with the penumbra of HSP75-injected animals. Only a diffuse background HNE staining was observed in the contralateral brain areas of all animals. HNE staining was observed in both core and penumbra, with a 1.9-fold rise on the injured side compared with contralateral of vectorinjected animals, whereas the Hsp75 injected animals had only a 1.26-fold rise ( Figure 4D ).
Effect of Hsp75 Overexpression on Mitochondrial Function
We measured the activities of individual mitochondrial complexes: NADH dehydrogenase (complex I), succinate dehydrogenase (complex II), ubiquinone dehydrogenase (complex III), and cytochrome c oxidase (complex IV) in Hsp75-and vector-injected animals 24 h after 100 mins MCAO. Figure 5 shows that although no differences were observed in complexes I to III activity between Hsp75 and vector-injected ischemic brains, the activity of complex IV, which has been shown to be particularly sensitive to free-radical damage (Heales et al, 1994) , was significantly higher in Hsp75-overexpressing brains, consistent with better preservation.
Hsp75 Protects Against Ischemic Depletion of Brain ATP Levels
ATP content was measured in both MCAO and shamoperated animals. As shown in Figure 6 first two bars, there was no significant difference in ATP levels between sham-operated Hsp75 or vectorinjected animals. Also, the hemispheres contralateral to MCAO treatment demonstrated ATP levels comparable to those of sham-operated animals. ATP content was significantly decreased in ipsilateral MCAO hemispheres of both Hsp75 and vectorinjected animals compared with the contralateral. However, Hsp75-overexpressing animals demonstrated a decrease of only 35%, whereas vectorinjected animals demonstrated a decrease of 66%, compared with the corresponding contralateral hemispheres.
Discussion
Heat shock protein 75 overexpression was previously shown to be protective against mitochondrial dysfunction, oxidative stress, and cell death induced by various forms of injury in vitro Voloboueva et al, 2007; Williamson et al, 2008) . Brain ischemia promotes damage to multiple subcellular sites, with mitochondria being considered Quantification of infarct volume shows a significant decrease in infarct volume in Hsp75-injected rats expressed as a percent of the volume of the hemisphere (*P = 0.025, n = 10 for vectorinjected, n = 10 for Hsp75-injected groups).
Hsp75 protects from focal ischemia L Xu et al one of the primary targets (Soane et al, 2007) . In this study we targeted mitochondria for protection by testing whether the mitochondrially localized chaperone Hsp75 when overexpressed in brain could protect brain cell function and increase overall brain viability after transient focal ischemic injury. Using DNA transfection, we obtained Hsp75 overexpression in both neurons and astrocytes, and observed a 43% decrease of infarct volume and improved neurological function after MCAO. Further studies are needed to assess whether this protection would still be detected after extended survival times and be reflected in greater functional recovery. Because Hsp75 overexpression was postulated to protect mitochondria and reduce oxidative stress, we evaluated ROS levels and lipid oxidation. Reactive oxygen species formation decreased 43% in the ischemic penumbra of Hsp75-overexpressing ani- Hsp75 overexpression ameliorates the reduction of ATP levels ipsilateral to MCAO. Brain was harvested 24 h after 100 mins MCAO and separated into ipsilateral to the infarct and contralateral hemispheres. In addition, brain was harvested from sham animals not subjected to MCAO (sham). Asterisk (*) indicates P < 0.05 compared with ipsilateral vector-injected hemisphere. Contra, contralateral hemisphere; Ipsi, ipsilateral hemisphere relative to the occlusion. n = 4 animals per group.
Hsp75 protects from focal ischemia L Xu et al mals compared with animals transfected with control DNA. Lipid peroxidation was reduced 50% with Hsp75 overexpression, demonstrating that oxidative damage to cell structures was indeed reduced with Hsp75 overexpression. Many studies have shown that cerebral ischemia/reperfusion promotes numerous enzymatic oxidation reactions that contribute to infarction (Chan, 2001; Siesjo et al, 1989) . Although there is increasing evidence that NADPH oxidase is important in ROS production (Sun et al, 2007) , mitochondria are also considered an important source of oxidative stress in cerebral ischemia reperfusion (Christophe and Nicolas, 2006; Fiskum et al, 2004) . Several mechanisms have been shown to stimulate mitochondrial ROS production during ischemia reperfusion, including nitric oxide inhibition of mitochondrial electron transport complexes (Brown and Borutaite, 2001 ) and apoptotic cytochrome c release (Starkov et al, 2002) . Also, the phenomenon of mitochondrial ROS-induced ROS release in which exposure to oxidative stress stimulates increased mitochondrial ROS production has been recently described (Zorov et al, 2006) .
Consistent with the importance of oxidative damage, earlier work has shown that overexpression of antioxidant enzymes, including cytosolic superoxide dismutase 1 and mitochondrial superoxide dismutase 2, provide protection against ischemic brain injury (Chan, 2001) . Heat shock protein 75 is a central component of the mitochondrial protein import machinery. Mitochondrial protein import is important in preservation of mitochondrial function during ischemic injury through delivery and replacement of essential and protective mitochondrial proteins. A previous study demonstrated that Hsp75 overexpression resulted in increased levels of mitochondrial superoxide dismutase 2 in cardiac myocytes (Williamson et al, 2008) ; thus, indicating one potential mechanism of the observed Hsp75 ischemic protection. Consistent with our work, others have also found reduced ROS generation with Hsp75 (Hua et al, 2007; Liu et al, 2005) .
To evaluate the effect of Hsp75 overexpression on mitochondrial function, we measured the activity of the mitochondrial complexes and found significantly higher levels of complex IV activity in Hsp75-overexpressing animals compared with vector-injected ones 24 h after focal ischemia. Complex IV function directly depends on the availability of the mitochondrial phospholipid cardiolipin (Robinson, 1993) . Cardiolipin is particularly susceptible to free-radical peroxidation, because of its high content of unsaturated fatty acids . Thus, the reduction of ROS levels and the associated reduction of cardiolipin peroxidation might be responsible for the Hsp75 protection of complex IV activity. Complex IV appears to be one of the most susceptible components of mitochondrial electron transport chain during brain ischemia (Heales et al, 1994) . Interestingly, complex IV activity in the heart is relatively insensitive to free-radical exposure (Cassina and Radi, 1996) . One possible explanation of the differential sensitivity may be that the cardiolipin concentration is several times lower in brain compared with heart (Ushmorov et al, 1999) , thus rendering complex IV activity in brain more sensitive to cardiolipin depletion.
The reduction of blood flow during MCAO strongly impairs energy generation, because of both oxygen starvation and glucose deprivation (Hertz, 2008) . Secondary postischemic energy failure after transient focal ischemia has been reported in several studies (Folbergrova et al, 1995; Hata et al, 2000; Lust et al, 2002) . This secondary failure may in part reflect persistent impairment of blood flow after ischemic injury (Takagi et al, 1995; van Dorsten et al, 1999) . Ischemia-induced impairment of mitochondrial oxidative phosphorylation would also contribute to delayed energy failure. Postischemic DNA repair causes additional depletion of intracellular ATP. Free radicals formed during ischemia/reperfusion induce DNA strand breaks that lead to activation of poly (ADP-ribose) polymerase (Kauppinen and Swanson, 2007; Koh et al, 2005) . poly(ADP-ribose) polymerase activity consumes NAD + thus slowing down glycolytic ATP production (Ying et al, 2005) . It has been shown that poly(ADP-ribose) polymerase hyperactivation rapidly impairs mitochondrial ATP production (Cipriani et al, 2005) . Reduced energy stores play a central role in neuronal loss (Zhu et al, 2004) , and several studies have demonstrated that astrocytes have greater protective effects if they do not have severe metabolic impairment (Dienel and Hertz, 2005; Swanson et al, 1997; Voloboueva et al, 2007) .
In our experiments, Hsp75 overexpression resulted in only 35% ATP depletion after focal ischemia compared with the 66% decrease measured in vector-injected animals. Thus, the Hsp75-associated decrease in ROS and lipid peroxidation as well as increased preservation of mitochondrial complex IV activity might contribute to the observed greater ATP preservation. These results are consistent with previous in vivo studies which demonstrated bioenergetic failure and mitochondrial dysfunction after 2 h of MCAO (Kuroda et al, 1996) . This was not because of permanent, structural damage, rather, transient reduction in complex IV activity was observed (Canevari et al, 1997) . Other studies indicate that electron transport chain activity may not be metabolically limiting in mitochondrial ATP production during reperfusion . Decreased production of NADH by pyruvate dehydrogenase and tricarboxylic acid cycle dehydrogenases , impaired flow of reducing equivalents between the components of the respiratory chain because of damage to mitochondrial membranes, and ROS-induced mitochondrial permeability transition activation (Kowaltowski et al, 2000) may all contribute to reduced mitochondrial ATP production without reduction in mitochondrial complex activities as measured under standard conditions in vitro.
Hsp75 protects from focal ischemia L Xu et al
Heat shock protein 75 has also been postulated to participate in regulation of apoptotic death and reduce release of cytochrome c from mitochondria after oxidative stress (Pridgeon et al, 2007; Taurin et al, 2002) . Thus, Hsp75 by protecting mitochondria likely directly contributes to reducing oxidative stress and reducing the induction of apoptosis, both relevant to the protection against cerebral ischemia observed here.
In conclusion, the results of this study demonstrate that in vivo overexpression of Hsp75 provides protection against ischemic brain injury. The reduced infarction and improved neuroscore was associated with decreased ROS levels, reduced tissue oxidative damage, better preserved mitochondrial function, and attenuated ATP loss. This study demonstrates that the protective mechanisms of Hsp75 reported in vitro also apply in focal ischemia in vivo. The data also provide evidence that protecting mitochondrial function, such as by Hsp75 overexpression, is a valid target for protection from cerebral ischemia.
